Skyclarys: payments to doctors
Payments that named Skyclarys as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.7M
- Providers
- 3,732
- Transactions
- 6,835
- Average per transaction
- $691
The per-transaction average — $691 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,732 providers the average total is $1,266, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Biogen | $4,722,943 | 100.0% |